在阿尔茨海默氏症和帕金森病中调节神经退行
Tim Bartels1, Sebastiaan De Schepper1, Soyon Hong2
1UK Dementia Research Institute, Institute of Neurology, University College London, London WC1E 6BT, UK.
概括
对于神经元的健康至关重要. 微质细胞与神经元之间的通信障碍可能导致神经退行性疾病,
科学领域:
- 神经科学
- 免疫学
- 神经退行性疾病
背景情况:
- 痴呆症是一个日益严重的全球健康问题,目前没有早期诊断生物标志物或有效的治疗方法.
- 传统上被认为是被动细胞的微细胞现在被认为是神经元功能和大脑平衡的积极调节者.
- 功能障碍的微细胞与神经元相互作用与神经退行性疾病的进展有关.
研究的目的:
- 阐明微质在维持神经元健康中的基本作用.
- 探讨微细胞与神经元交叉交谈的慢性损伤导致阿尔茨海默氏症和帕金森病的突触和神经元功能障碍的假设.
- 强调了解和调节微细胞与神经元相互作用对于开发痴呆症治疗的重要性.
主要方法:
- 对成年人大脑中微质功能的当前文献的审查和综合.
- 对微质-神经元通信缺陷与神经退行相关的拟议机制的分析.
- 评估和调节微细胞与神经元相互作用的概念框架的开发.
主要成果:
- 微质在控制神经元功能和维持大脑平衡方面发挥着至关重要的作用.
- 在阿尔茨海默氏症和帕金森氏症中观察到的神经元功能持续衰竭的关键因素是微质神经元交叉交谈的慢性损伤.
- 针对微细胞与神经元的相互作用, 是对痴呆症的有希望的治疗途径.
结论:
- 微细胞对神经元健康和突触功能至关重要.
- 缺陷的微细胞-神经元通信是痴呆症发病的一个潜在驱动因素.
- 开发评估和调整这些相互作用的策略对于未来的痴呆症治疗至关重要.
相关概念视频
Neural Regulation
42.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.6K
Parkinson's Disease: Overview
1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Alzheimer's Disease: Overview
1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Alzheimer's Disease: Treatment
630
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
630


